A model for building a national, patient-driven database to track contraceptive use in women with rare diseases.
Data on the safety and effectiveness of contraception among women with rare diseases are critical and sorely lacking. To fill this gap, we propose a national, patient-driven database that tracks contraceptive safety and effectiveness among women with rare diseases. We built a pilot database focusing on women with cystic fibrosis in 3 phases: (1) database design input from patients and experts, (2) merging of contraceptive survey data with relevant clinical outcomes [...]
Author(s): Josephy, Tatiana, Loeffler, Deena R, Pam, Molly, Godfrey, Emily M
DOI: 10.1093/jamia/ocab224